Healthcare

Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, has reported a decline in adjusted earnings for the fourth quarter…

Humana Inc. (NYSE: HUM) reported its fourth quarter 2025 earnings results today. Total revenues were $32.5 billion compared to $29.2…

Shares, 52-Week Range, Recent Trend   Quest Diagnostics Inc. (NYSE: DGX) shares rose sharply following its Q4 and FY 2025…

Medpace Holdings, Inc. (NASDAQ: MEDP) delivered a strong fourth quarter with significant top-line and bottom-line growth, beating analyst estimates. However,…

InMode Ltd (NASDAQ: INMD) reported its financial results for the fourth quarter and full year ended December 31, 2025, showing…

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) closed at $93.60, up 4.3% on the day, after reporting fourth-quarter and full-year 2025…

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year increase driven by demand for…

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a 7.8% increase over the prior…

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues for the fourth quarter of…

Waters Corporation (WAT) shares dropped 14.49% to $326.04 in early trading on Tuesday after the life sciences company issued 2026…